The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 63 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Renal Insufficiency, Chronic  [Clear All Filters]
2020
Moralidis, E., Papanastasiou E., Didangelos T., Hilidis I., Siountas A., & Arsos G. (2020).  Determination of the glomerular filtration rate in patients with type 2 diabetes: An assessment of the agreement between Cr-EDTA plasma clearance and Tc-DTPA plasma clearance, Tc-DTPA renography and plasma creatinine prediction equation.. Diabetes Res Clin Pract. 161, 108079.
Li, P. Kam- Tao, Garcia-Garcia G., Lui S-F., Andreoli S., Fung W. Wing- Shing, Hradsky A., et al. (2020).  Kidney health for everyone everywhere - from prevention to detection and equitable access to care.. Clin Nephrol. 93(3), 111-122.
P Li, K-T., Garcia-Garcia G., Lui S-F., Andreoli S., W Fung W-S., Hradsky A., et al. (2020).  Kidney health for everyone everywhere - from prevention to detection and equitable access to care.. Braz J Med Biol Res. 53(3), e9614.
P Li, K-T., Garcia-Garcia G., Siu-Fai L., Andreoli S., W Fung W-S., Hradsky A., et al. (2020).  Kidney Health for Everyone Everywhere - from Prevention to Detection and Equitable Access to Care.. West Afr J Med. 37(4), 368-376.
Li, P. Kam- Tao, Garcia-Garcia G., Lui S-F., Andreoli S., Fung W. Wing- Shing, Hradsky A., et al. (2020).  Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care.. J Ren Care. 46(1), 4-12.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
2019
Roumeliotis, S., Dounousi E., Eleftheriadis T., & Liakopoulos V. (2019).  Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.. Int J Mol Sci. 20(3), 
Heerspink, H. J. L., Parving H-H., Andress D. L., Bakris G., Correa-Rotter R., Hou F-F., et al. (2019).  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.. Lancet. 393(10184), 1937-1947.
Karava, V., Printza N., Dotis J., Demertzi D., Antza C., Kotsis V., et al. (2019).  Body composition and arterial stiffness in pediatric patients with chronic kidney disease.. Pediatr Nephrol. 34(7), 1253-1260.
Roumeliotis, S., Roumeliotis A., Dounousi E., Eleftheriadis T., & Liakopoulos V. (2019).  Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review.. Nutrients. 11(8), 
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Stavrinou, E., Sarafidis P. A., Koumaras C., Loutradis C., Giamalis P., Tziomalos K., et al. (2019).  Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.. Kidney Blood Press Res. 44(4), 679-689.
Dufek, S., Ylinen E., Trautmann A., Alpay H., Ariceta G., Aufricht C., et al. (2019).  Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases.. Pediatr Nephrol. 34(4), 649-655.
Anagnostis, P., & Goulis D. G. (2019).  Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease".. J Clin Endocrinol Metab. 104(8), 3124.
Roumeliotis, S., Eleftheriadis T., & Liakopoulos V. (2019).  Is oxidative stress an issue in peritoneal dialysis?. Semin Dial. 32(5), 463-466.
Duni, A., Liakopoulos V., Roumeliotis S., Peschos D., & Dounousi E. (2019).  Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread.. Int J Mol Sci. 20(15), 
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Stabouli, S., Gidaris D., Printza N., Dotis J., Papadimitriou E., Chrysaidou K., et al. (2019).  Sleep disorders and executive function in children and adolescents with chronic kidney disease.. Sleep Med. 55, 33-39.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.